Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PJ5B | ISIN: KYG4672N1198 | Ticker-Symbol: H7T2
Frankfurt
20.11.24
08:24 Uhr
2,980 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
HUTCHMED CHINA LIMITED Chart 1 Jahr
5-Tage-Chart
HUTCHMED CHINA LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
3,2003,52013:15
3,4203,58005.11.

Aktuelle News zur HUTCHMED Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
HUTCHMED Aktie jetzt für 0€ handeln
10:08HUTCHMED (00013): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS2
MiHUTCHMED Ltd - 6-K, Report of foreign issuer-
MiHUTCHMED (China) Limited: HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee1
MiHUTCHMED (00013): HUTCHMED ANNOUNCES APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND MEMBER OF BOARD COMMITTEE-
MiHutchmed China Ltd - Appointment of Independent Non-executive Director-
06.11.HUTCHMED Ltd - 6-K, Report of foreign issuer-
06.11.Hutchmed China Ltd - Clinical Data to be Presented at ASH and ESMO Asia-
06.11.HUTCHMED (China) Limited: HUTCHMED Highlights Clinical Data to be Presented at the 2024 ASH Annual Meeting and the 2024 ESMO Asia Congress1
06.11.HUTCHMED (00013): VOLUNTARY ANNOUNCEMENT - HUTCHMED HIGHLIGHTS CLINICAL DATA TO BE PRESENTED AT THE 2024 ASH ANNUAL MEETING AND THE 2024 ESMO ASIA CONGRESS1
31.10.Hutchmed China receives first milestone payment for Takeda drug sales6
31.10.Hutchmed to receive $20m Fruzaqla milestone payment2
31.10.HUTCHMED (China) Limited: HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA (fruquintinib) Sales by Takeda107HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:?HCM; HKEX:?13) today announces that it will receive a US$20 million...
► Artikel lesen
31.10.HUTCHMED (00013): TOTAL VOTING RIGHTS1
31.10.HUTCHMED (00013): VOLUNTARY ANNOUNCEMENT - HUTCHMED TO RECEIVE FIRST COMMERCIAL MILESTONE PAYMENT FOLLOWING OVER US$200 MILLION IN FRUZAQLA (FRUQUINTINIB) ...3
31.10.Hutchmed China Ltd - Total Voting Rights1
31.10.Hutchmed China Ltd - First Commercial Milestone Payment-
21.10.HUTCHMED (00013): VESTING OF AWARDS UNDER THE LONG TERM INCENTIVE PLAN-
21.10.Hutchmed China Ltd - Vesting of awards under the LTIP-
16.10.Hutchmed reports positive results from AstraZeneca lung cancer collaboration4
16.10.HUTCHMED Ltd - 6-K, Report of foreign issuer1
Seite:  Weiter >>
128 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1